Healthcare provider profile · identity verified

John Rosson, APRN-CNP

Nurse Practitioner · EUFAULA, OK · NPI 1982149225

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	259	80
Atorvastatin Calcium	Atorvastatin Calcium	236	79
Omeprazole	Omeprazole	222	73
Lisinopril	Lisinopril	186	66
Amlodipine Besylate	Amlodipine Besylate	178	59
Gabapentin	Gabapentin	164	59
Albuterol Sulfate Hfa	Albuterol Sulfate	135	57
Losartan Potassium	Losartan Potassium	133	49
Pregabalin	Pregabalin	132	19
Prednisone	Prednisone	125	90
Tramadol Hcl	Tramadol Hcl	112	24
Hydrochlorothiazide	Hydrochlorothiazide	109	42
Pantoprazole Sodium	Pantoprazole Sodium	104	34
Metoprolol Succinate	Metoprolol Succinate	100	35
Duloxetine Hcl	Duloxetine Hcl	97	27
Furosemide	Furosemide	96	39
Potassium Chloride	Potassium Chloride	96	36
Montelukast Sodium	Montelukast Sodium	89	31
Ventolin Hfa	Albuterol Sulfate	81	34
Trazodone Hcl	Trazodone Hcl	80	31
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	79	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	78	28
Zolpidem Tartrate	Zolpidem Tartrate	78	12
Rosuvastatin Calcium	Rosuvastatin Calcium	76	28
Eliquis	Apixaban	75	25
Ozempic	Semaglutide	74	26
Temazepam	Temazepam	74	suppressed
Clopidogrel	Clopidogrel Bisulfate	72	27
Carvedilol	Carvedilol	70	22
Simvastatin	Simvastatin	68	21
Meloxicam	Meloxicam	67	27
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	66	32
Metformin Hcl	Metformin Hcl	64	24
Azithromycin	Azithromycin	61	52
Allopurinol	Allopurinol	56	16
Metoprolol Tartrate	Metoprolol Tartrate	55	21
Diclofenac Sodium	Diclofenac Sodium	52	16
Januvia	Sitagliptin Phosphate	51	17
Ondansetron Odt	Ondansetron	51	17
Hydroxyzine Pamoate	Hydroxyzine Pamoate	50	20
Alendronate Sodium	Alendronate Sodium	49	15
Buspirone Hcl	Buspirone Hcl	48	16
Glimepiride	Glimepiride	48	15
Sertraline Hcl	Sertraline Hcl	48	18
Fluoxetine Hcl	Fluoxetine Hcl	47	12
Metformin Hcl Er	Metformin Hcl	47	14
Baclofen	Baclofen	46	20
Fluticasone Propionate	Fluticasone Propionate	44	24
Ropinirole Hcl	Ropinirole Hcl	40	15
Xarelto	Rivaroxaban	39	16
Glipizide	Glipizide	38	13
Citalopram Hbr	Citalopram Hydrobromide	37	13
Nystatin	Nystatin	37	18
Donepezil Hcl	Donepezil Hcl	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	36	suppressed
Ezetimibe	Ezetimibe	35	11
Lorazepam	Lorazepam	35	suppressed
Ibuprofen	Ibuprofen	34	17
Clonazepam	Clonazepam	33	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	12
Pravastatin Sodium	Pravastatin Sodium	33	12
Atenolol	Atenolol	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	14
Famotidine	Famotidine	31	suppressed
Jardiance	Empagliflozin	31	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	14
Oxybutynin Chloride	Oxybutynin Chloride	30	11
Cefdinir	Cefdinir	27	23
Fenofibrate	Fenofibrate Nanocrystallized	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	26	11
Naproxen	Naproxen	25	12
Valsartan	Valsartan	25	suppressed
Bumetanide	Bumetanide	24	suppressed
Enalapril Maleate	Enalapril Maleate	24	suppressed
Levofloxacin	Levofloxacin	23	21
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Trulicity	Dulaglutide	23	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Bupropion Xl	Bupropion Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	20	suppressed
Mupirocin	Mupirocin	20	17
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Hydrocortisone	Hydrocortisone	19	12
Colchicine	Colchicine	18	suppressed
Linzess	Linaclotide	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	14
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Celecoxib	Celecoxib	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Promethazine Hcl	Promethazine Hcl	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	11
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	15	suppressed
Finasteride	Finasteride	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Glucagon Emergency Kit	Glucagon	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Topiramate	Topiramate	14	suppressed
Amoxicillin	Amoxicillin	13	12
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Trueplus Pen Needle	Pen Needle, Diabetic	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Colestipol Hcl	Colestipol Hcl	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Phenytek	Phenytoin Sodium Extended	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clarithromycin	Clarithromycin	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error